Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …

The clinical approval of the first nanoparticle-based drug, liposomal doxorubicin (Doxil®), for
cancer therapy in the United States in 1995 has marked the entrance of nanomedicines in …

Lipid nanoparticles (LNPs) can be designed to potentiate cancer immunotherapy by
promoting their uptake by antigen-presenting cells, stimulating the maturation of these cells …

Microfluidics is an emerging technology that can be employed as a powerful tool for
designing lipid nano-microsized structures for biological applications. Those lipid structures …

Clinical hyperthermic intraperitoneal chemotherapy (HIPEC) is regarded as a potential
treatment that can prolong survival of patients with peritoneal metastases after cytoreductive …

Cancer immunotherapy has gained popularity in recent years in the search for effective
treatment modalities for various malignancies, particularly those that are resistant to …

Broad size distributions and poor long‐term colloidal stability of microRNA‐carrying
nanoparticles, especially those formed by polyelectrolyte complexation, represent major …

The recent development of RNA‐based therapeutics in delivering nucleic acids for gene
editing and regulating protein translation has led to the effective treatment of various …

Single-stranded messenger ribonucleic acid (mRNA) plays a pivotal role in transferring
genetic information, and tremendous effort has been devoted over the years to utilize its …

Peptide/protein therapeutics have been significantly applied in the clinical treatment of
various diseases such as cancer, diabetes, etc. owing to their high biocompatibility …